MP Cough Syrup Deaths: PIL In Supreme Court Seeks CBI Probe, Retired SC Judge-Monitored Investigation

MP Cough Syrup Deaths: A Public Interest Litigation (PIL) has been filed before the Supreme Court seeking CBI investigation into the death of 14 children from Madhya Pradesh’s Chhindwara due to suspected renal failure, linked to the consumption of a "toxic" cough syrup.

The PIL filed by a lawyer seeks a retired Supreme Court judge-monitored probe and inquiry into the manufacture, regulation, testing and distribution of contaminated cough syrups, as per news agency ANI.

The police have arrested the doctor who prescribed the Coldrif syrup. Most of the patients were admitted at the clinic of pediatrician Praveen Soni in Chhindwara. Apart from this, the state government also filed a case against Srisan Pharmaceuticals for manufacturing the syrup that deteriorated the health of the children.

ALSO READ: Rakesh Kishore: From Bar Council Member To Controversial Society President; Man Behind CJI Gavai Shoe Incident

Adulterated Cough Syrup Tested In Tamil Nadu

Tamil Nadu drug control authorities, in their report dated October 2, declared the Coldrif syrup sample (Batch No SR-13; Mfg: May 2025; Exp: April 2027) manufactured by Sresan Pharmaceuticals, Kancheepuram, as adulterated because it contained diethylene glycol (48.6 per cent w/v), a poisonous substance "which may render the contents injurious to health”.

ALSO READ: Bihar Election 2025: When Is Voting In Patna? Check Dates, Full List Of Constituencies In Phase 1 And 2

Following the report, the Madhya Pradesh Food and Drug Administration issued instructions to stop further sale and distribution of Coldrif statewide and immediately seize any available stock for investigation under the Drugs and Cosmetics Act, 1940. It also ordered that other products manufactured by Sresan Pharmaceuticals be removed from sale pending testing.